Published in Infect Control Hosp Epidemiol on November 17, 2006
Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect Control Hosp Epidemiol (2010) 3.08
Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol (2010) 1.16
Attributable costs of surgical site infection and endometritis after low transverse cesarean delivery. Infect Control Hosp Epidemiol (2010) 1.07
Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in Italy. Cost Eff Resour Alloc (2010) 1.06
Laparoscopic surgery significantly reduces surgical-site infections compared with open surgery. Surg Endosc (2009) 0.96
Surgical site infections--economic consequences for the health care system. Langenbecks Arch Surg (2011) 0.93
Comparison of surgical-site infection between open and laparoscopic appendectomy. J Korean Surg Soc (2011) 0.82
Incidence of Nosocomial Infections in a Big University Affiliated Hospital in Shiraz, Iran: A Six-month Experience. Int J Prev Med (2013) 0.81
The burden of nosocomial staphylococcus aureus bloodstream infection in South Korea: a prospective hospital-based nationwide study. BMC Infect Dis (2014) 0.80
Improving environmental quality in an operating room: clinical outcomes and economic implications. J Prev Med Hyg (2013) 0.77
The cost of infection in severe open tibial fractures treated with a free flap. Int Orthop (2016) 0.75
Quantifying the effect of complications on patient flow, costs and surgical throughputs. BMC Med Inform Decis Mak (2016) 0.75
Association between elevated pre-operative glycosylated hemoglobin and post-operative infections after non-emergent surgery. Ann Med Surg (Lond) (2016) 0.75
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis (2004) 20.99
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med (2013) 11.85
Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA (2002) 10.40
Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med (2013) 7.75
Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med (2004) 5.47
Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med (2002) 5.39
Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm (2013) 5.02
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis (2010) 4.98
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis (2008) 4.79
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol (2004) 4.70
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis (2009) 4.59
Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics (2005) 4.39
Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis (2009) 4.33
Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis (2013) 4.14
Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis (2007) 3.73
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis (2003) 3.53
Has antifungal susceptibility testing come of age? Clin Infect Dis (2002) 3.39
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis (2003) 3.39
Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis (2004) 3.20
Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 3.13
Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension (2006) 3.02
In Candida albicans, white-opaque switchers are homozygous for mating type. Genetics (2002) 2.96
Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol (2008) 2.90
Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol (2007) 2.77
Central retinal artery occlusion: visual outcome. Am J Ophthalmol (2005) 2.69
Central retinal artery occlusion. Retinal survival time. Exp Eye Res (2004) 2.67
Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis (2003) 2.54
Screening inpatients for MRSA--case closed. N Engl J Med (2013) 2.44
Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol (2008) 2.40
Google Flu Trends: correlation with emergency department influenza rates and crowding metrics. Clin Infect Dis (2012) 2.34
A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.32
Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.30
Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol (2005) 2.26
Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob (2004) 2.24
Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev (2011) 2.22
Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.22
Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J (2003) 2.22
Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology (2007) 2.17
Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis (2008) 2.16
Designing a safer process to prevent retained surgical sponges: a healthcare failure mode and effect analysis. AORN J (2011) 2.12
Bacteremias: a leading cause of death. Arch Med Res (2005) 2.09
A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol (2002) 2.08
Vancomycin resistance in staphylococci. Clin Microbiol Rev (2002) 2.07
Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains. Antimicrob Agents Chemother (2010) 2.03
Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother (2011) 2.01
Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis (2006) 1.97
Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet (2013) 1.94
A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol (2006) 1.93
An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis (2012) 1.90
Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta (2012) 1.89
Contact precautions: more is not necessarily better. Infect Control Hosp Epidemiol (2014) 1.88
Catheter duration and risk of CLA-BSI in neonates with PICCs. Pediatrics (2010) 1.88
Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis (2007) 1.87
Fundus changes in central retinal artery occlusion. Retina (2007) 1.85
Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.84
Use of herbs among adults based on evidence-based indications: findings from the National Health Interview Survey. Mayo Clin Proc (2007) 1.84
Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis (2002) 1.83
Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.81
Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagn Microbiol Infect Dis (2007) 1.80
Retinal artery occlusion: associated systemic and ophthalmic abnormalities. Ophthalmology (2009) 1.78
The critically ill child with novel H1N1 influenza A: a case series. Pediatr Crit Care Med (2010) 1.77
First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother (2011) 1.74
Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc (2009) 1.74
Diurnal cortisol variations and symptoms in patients with interstitial cystitis. J Urol (2002) 1.73
Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.66
Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J Clin Microbiol (2008) 1.66
An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med (2003) 1.65
Natural history of visual outcome in central retinal vein occlusion. Ophthalmology (2010) 1.64
Reduction of catheter-associated bloodstream infections in pediatric patients: experimentation and reality. Pediatr Crit Care Med (2008) 1.63
Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J Infect (2011) 1.61
Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics (2005) 1.61
Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients. Ophthalmology (2008) 1.60
Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med (2002) 1.60
Middle East respiratory syndrome coronavirus in healthcare settings. Curr Opin Infect Dis (2015) 1.60
Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) (2013) 1.60
An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA (2004) 1.59
Branch retinal artery occlusion: natural history of visual outcome. Ophthalmology (2009) 1.58
Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res (2010) 1.57
Enhanced identification of postoperative infections among inpatients. Emerg Infect Dis (2004) 1.56
Knowledge, awareness, and attitudes regarding methicillin-resistant Staphylococcus aureus among caregivers of hospitalized children. J Pediatr (2010) 1.54
The new Clostridium difficile--what does it mean? N Engl J Med (2005) 1.53
Past history of skin infection and risk of surgical site infection after elective surgery. Ann Surg (2013) 1.52
A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol (2006) 1.51
Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis (2002) 1.51
Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance. Clin Infect Dis (2013) 1.50
Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans. Antimicrob Agents Chemother (2004) 1.49
Flucytosine resistance is restricted to a single genetic clade of Candida albicans. Antimicrob Agents Chemother (2004) 1.49
Hepatic iron overload in blacks and whites: a comparative autopsy study. Am J Gastroenterol (2003) 1.49
Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol (2003) 1.47
Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrix-assisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs. J Clin Microbiol (2012) 1.47
Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol (2003) 1.46
Bronchoscope reprocessing and infection prevention and control: bronchoscopy-specific guidelines are needed. Chest (2004) 1.45
National surveillance of herbal dietary supplement exposures: the poison control center experience. Pharmacoepidemiol Drug Saf (2007) 1.45